Cargando…
Pyruvate is a prospective alkalizer to correct hypoxic lactic acidosis
Type A lactic acidosis resulted from hypoxic mitochondrial dysfunction is an independent predictor of mortality for critically ill patients. However, current therapeutic agents are still in shortage and can even be harmful. This paper reviewed data regarding lactic acidosis treatment and recommended...
Autores principales: | Wang, Ying, Huang, Ya, Yang, Jing, Zhou, Fang-Qiang, Zhao, Lian, Zhou, Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5918562/ https://www.ncbi.nlm.nih.gov/pubmed/29695298 http://dx.doi.org/10.1186/s40779-018-0160-y |
Ejemplares similares
-
Pyruvate carboxylase deficiency: An underestimated cause of lactic acidosis
por: Habarou, F., et al.
Publicado: (2014) -
Hemodialysis for Lactic Acidosis
por: Karthiraj, N., et al.
Publicado: (2017) -
Pyruvate Dehydrogenase Complex Deficiency: An Unusual Cause of Recurrent Lactic Acidosis in a Paediatric Critical Care Unit
por: Gupta, Neha, et al.
Publicado: (2019) -
Loss of muscle PDH induces lactic acidosis and adaptive anaplerotic compensation via pyruvate-alanine cycling and glutaminolysis
por: Gopal, Keshav, et al.
Publicado: (2023) -
Metformin-Associated Lactic Acidosis
por: Suh, Sunghwan
Publicado: (2015)